Cite

    Zamarripa, C. et al. (2020). The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats. Behavioural pharmacology. 31 (8), p. . [Online].